Bank of America
BIS icon

Bank of America’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Bank of America’s Portfolio BIS Stock Details BIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-125
Closed -$24K – 7055
2017
Q2 		$24K Hold
125
– – ﹤0.01% 6162
2017
Q1 		$28K Hold
125
– – ﹤0.01% 6173
2016
Q4 		$35K Hold
125
– – ﹤0.01% 6084
2016
Q3 		$32K Hold
125
– – ﹤0.01% 5917
2016
Q2 		$42K Hold
125
– – ﹤0.01% 5905
2016
Q1 		$44K Hold
125
– – ﹤0.01% 5832
2015
Q4 		$29K Hold
125
– – ﹤0.01% 6275
2015
Q3 		$39K Buy
+125
New +$29.5K ﹤0.01% 6042
2014
Q2 		– Sell
-50
Closed -$36K – 8012
2014
Q1 		$36K Buy
+50
New +$33.4K ﹤0.01% 6605

Other funds holding BIS

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Bank of America's BIS Position: Q3 2017 in Review

Bank of America sold out of ProShares UltraShort NASDAQ Biotechnology (BIS) in Q3 2017, closing a stake of 125 shares — an estimated $24K sold.

Bank of America first reported a position in BIS in Q1 2014 and held it in 9 quarters. The position peaked at $44K in Q1 2016. 9 funds tracked by Wall St. Rank hold BIS as of Q3 2017.

  • Bank of America reported no remaining ProShares UltraShort NASDAQ Biotechnology position as of Q3 2017 after selling out during the quarter.
  • Bank of America sold 125 ProShares UltraShort NASDAQ Biotechnology shares in Q3 2017, an estimated $24K.
  • Bank of America first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q1 2014 and held it in 9 quarters.
  • Bank of America's ProShares UltraShort NASDAQ Biotechnology position peaked at $44K in Q1 2016.
  • 9 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q3 2017.

Based on Bank of America's 13F filing for Q3 2017, filed 14 Nov 2017.